Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Med-X's Enterprise Value is $0.00 Mil.
Med-X's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-7.32 Mil. Therefore, Med-X's EV-to-EBIT for today is 0.00.
The historical rank and industry rank for Med-X's EV-to-EBIT or its related term are showing as below:
MXRX's EV-to-EBIT is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 12.16 * Ranked among companies with meaningful EV-to-EBIT only.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Med-X's Enterprise Value for the quarter that ended in Dec. 2022 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Med-X's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-7.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med-X EV-to-EBIT Related Terms
Med-X EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Med-X's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med-X EV-to-EBIT Chart
Med-X Annual Data
Trend
Dec20
Dec21
Dec22
EV-to-EBIT
0.00
0.00
0.00
Med-X Semi-Annual Data
Dec20
Jun21
Dec21
Jun22
Dec22
EV-to-EBIT
0.00
0.00
0.00
0.00
0.00
MXRX vs : EV-to-EBIT Comparison
For the Household & Personal Products subindustry, Med-X's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med-X EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Med-X's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Med-X's EV-to-EBIT falls into.
Med-X's current Enterprise Value is $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Med-X's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-7.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Med-X (MXRX) has a EV-to-EBIT of 0.00 as of Aug. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Med-X and its competitors.
Is Med-X's EV-to-EBIT too high?
Med-X's current EV-to-EBIT is 0.00.
How does Med-X's EV-to-EBIT compare to ?
Med-X's EV-to-EBIT of 0.00 can be compared against companies in the Consumer Packaged Goods industry. The industry median EV-to-EBIT is 12.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.16, based on 1,557 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Med-X and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med-X's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med-X stock overvalued right now?
Med-X (MXRX) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Med-X (MXRX), the current EV-to-EBIT is 0.00 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Med-X Inc is engaged in the business of product development, distribution, and marketing of products, which currently consist of Nature-Cide, Thermal-Aid, and Malibu Brands. Nature-Cide products include natural essential oil blends of indoor and outdoor pesticide/insecticide/repellent developed for multiple industries, including professional pest control, turf care, janitorial, hospitality, transportation, and agriculture. Thermal-Aid, Thermal-Aid Zoo, and the Thermal-Aid Headache Relief System are natural heating/cooling pain and physical therapy products for painful ailments affecting adults, children, and animals. Nature-Cide. Malibu Brands has only one product available, an all-natural essential oil pain management cream.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MXRX has been successfully added to your 
